MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    The Impact of Delaying Subcutaneous Device-Aided Therapy for Patients with Advanced Parkinson’s Disease

    R. Wiggins, J. Lee, T. Boodhna, O. Yip, J. Homola, L. Pronk, R. van Den Puttelaar, J. Aldred (Charlotte, USA)

    Objective: This study aims to evaluate the clinical, humanistic, and societal impact of delayed SC therapy in patients with PD. Background: As Parkinson’s disease (PD)…
  • 2026 International Congress

    Sudomotor Dysfunction in Patients With Normal and Abnormal Cardiac MIBG

    Z. Jiang, G. Chiaro, V. Iodice (London, United Kingdom)

    Objective: We examined the pattern of sweat loss in patients with normal versus abnormal MIBG and considered the implications of this in predicting phenoconversion trajectory.…
  • 2026 International Congress

    Oral D1-like/D2-like Receptor Agonist, Lu AF28996, Provides Robust Antiparkinsonian Efficacy with Reduced Dyskinesia in the MPTP-Macaque Model

    H. Lindgren, E. Bezard (Copenhagen, Denmark)

    Objective: Evaluate the therapeutic potential of Lu AF28996 in the MPTP-macaque model of PD. Background: Chronic levodopa treatment is associated with the development of motor…
  • 2026 International Congress

    “Shaky Eyes”: an Unusual Case of Ocular Movement Disorder

    A. Mechelli, A. Gozzi, P. Antenucci, G. Linzalone, A. Ciorba, D. Gragnaniello, J. Capone, M. Sensi (Ferrara, Italy)

    Objective: To report an unusual video case of paroxysmal conjugate saccadic ocular oscillations and discuss the challenges in the diagnostic process differentiating ocular movement disorders.…
  • 2026 International Congress

    A Novel Clinical Protocol for Monitoring Therapeutic Outcomes in Camptocormia in Parkinson´s Disease

    L. Lundh, E. Franzén, S. Grigoriou, M. Söderholm, W. Duzynski, F. Strömqvist, B. Lindholm (Ängelholm, Sweden)

    Objective: To present a case study using a novel protocol evaluating postural, pain, and respiratory outcome in PD-related camptocormia before and after treatment. Background: Camptocormia…
  • 2026 International Congress

    Parkinson’s Disease Early Diagnostic and Prognostic Biomarkers Identified by Large-scale Plasma and Cerebrospinal Fluid Proteomic Profiling

    XY. Li, YL. Tang, J. Wang (Shanghai, China)

    Objective: To identify reliable diagnostic and prognostic protein biomarkers for early-stage Parkinson’s disease (PD) using large-scale proteomic profiling of plasma and cerebrospinal fluid (CSF).To identify…
  • 2026 International Congress

    Nutritional Assessment in X-linked Dystonia Parkinsonism: Preliminary Results from a Pilot Study

    PD. Lanuza, MM. Tabuzo-Acuin, FL. Libre, JM. Pascual, NK. Reyes, RD. Jamora (Manila, Philippines)

    Objective: This pilot study aims to evaluate the nutritional status of XDP patients using anthropometric measurements and nutritional assessment tools, and to determine the prevalence…
  • 2026 International Congress

    Levodopa-Responsive Dystonia in Adenylosuccinate Lyase (ADSL) Deficiency Treated With Bilateral GPi Deep Brain Stimulation

    K. Ibarra, M. San Luciano (San Francisco, USA)

    Objective: To describe levodopa-responsive dystonia in ADSL deficiency and the use of bilateral globus pallidus internus (GPi) deep brain stimulation (DBS) for refractory symptoms. Background:…
  • 2026 International Congress

    Digital Health, Telemedicine, and Artificial Intelligence in Parkinson’s Disease Management During COVID-19: A Narrative Review

    H. Harifi (Kenitra, Morocco)

    Objective: The objective of this narrative review was to evaluate the effectiveness of telemedicine and AI-based technologies used for the remote monitoring and management of…
  • 2026 International Congress

    Effectiveness and Safety of Deutetrabenazine in Chinese Patients with Huntington’s Disease-associated Chorea: A Multicenter Phase 4 Study

    Y. Cheng, Y. Huang, J. Ma, J. Yin, X. Dan, J. Qu, Y. Li, G. Zhang, KT. Ustundag, AP. Levin, R. Ribalov, H. Xie, R. Eshet, M. Zeygarnik, J. Wang, H. Shang (Chengdu, China)

    Objective: To evaluate the effectiveness and safety of deutetrabenazine (DTBZ) in Chinese patients with Huntington’s Disease (HD)-associated chorea. Background: Chorea is a key symptom of…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley